Pila Pharma AB (publ) (PILA.ST)
SEK 3.87
(5.16%)
SEK 3.87
(5.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.85 Million | -9.09 Million | -9.36 Million | -2 Million | -5.02 Million | -4.56 Million |
| Net Income | -9.93 Million | -26.77 Million | -17.2 Million | -6.98 Million | -8.66 Million | -5.6 Million |
| Depreciation & Amortization | 1.07 Million | 15.63 Thousand | 20.14 Thousand | 20.14 Thousand | 20.14 Thousand | 17.13 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 502 Thousand | -216 Thousand | -93 Thousand | 1.35 Million | -324.19 Thousand | 370.34 Thousand |
| Other non-cash items | 3.49 Million | 17.88 Million | 7.91 Million | 3.6 Million | 3.95 Million | 650 Thousand |
| Investing Cash Flow | - | - | - | - | -15.07 Thousand | -3.18 Million |
| Investments in PPE | - | - | - | - | -15.07 Thousand | -3.18 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 3.56 Million | -11.87 Million | 35.66 Million | -158.06 Thousand | 5.68 Million | 4.4 Million |
| Debt repayment | -1.5 Million | - | -500 Thousand | -500 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -3.6 Million | -3.95 Million | -650 Thousand |
| Common Stock Issuance | 7.06 Million | 6.01 Million | 44.08 Million | 2.94 Million | 9.63 Million | 5.13 Million |
| Other Financing Activities | -3.49 Million | -17.88 Million | -7.91 Million | 500 Thousand | -3.95 Million | -80 Thousand |
| Accounts receivables | 66 Thousand | -58 Thousand | -162 Thousand | 397 Thousand | - | - |
| Accounts payables | 821 Thousand | -3000.00 | 138 Thousand | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -385 Thousand | -155 Thousand | -69 Thousand | 961.8 Thousand | - | - |
| Cash at beginning of period | 7.24 Million | 28.2 Million | 1.9 Million | 4.06 Million | 3.42 Million | 6.76 Million |
| Cash at end of period | 5.95 Million | 7.24 Million | 28.2 Million | 1.9 Million | 4.06 Million | 3.42 Million |
| Capital Expenditure | - | - | - | - | -15.07 Thousand | -3.18 Million |
| Effect of forex changes on cash | - | - | - | - | 1.00 | -1.00 |
| Net cash flow / Change in cash | -1.28 Million | -20.96 Million | 26.3 Million | -2.15 Million | 645.42 Thousand | -3.33 Million |
| Free Cash Flow | -4.85 Million | -9.09 Million | -9.36 Million | -2 Million | -5.03 Million | -7.74 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.04 Million | -2.04 Million | -1.3 Million | -9.93 Million | -1.53 Million | -3.05 Million |
| Depreciation & Amortization | 269.5 Thousand | 269.5 Thousand | 270 Thousand | 1.07 Million | 269 Thousand | 269 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -126 Thousand | -126 Thousand | 277 Thousand | 502 Thousand | 465 Thousand | -150 Thousand |
| Other non-cash items | 194 Thousand | 194 Thousand | -1000.00 | 3.49 Million | 1000.00 | 1.3 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | 5.56 Million | 3.56 Million | 1.5 Million | -1.3 Million |
| Debt repayment | - | - | -1.5 Million | -1.5 Million | -1.5 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 7.06 Million | 7.06 Million | - | - |
| Other Financing Activities | - | - | 5.56 Million | -3.49 Million | 1.5 Million | -1.3 Million |
| Accounts receivables | 9000.00 | 9000.00 | 120 Thousand | 66 Thousand | -140 Thousand | 159 Thousand |
| Accounts payables | - | - | 1.01 Million | 821 Thousand | 114 Thousand | -237 Thousand |
| Inventory | - | - | 1.00 | - | -1000.00 | 1000.00 |
| Other working capital | -135 Thousand | -135 Thousand | -860 Thousand | -385 Thousand | 492 Thousand | -73 Thousand |
| Cash at beginning of period | - | 5.95 Million | 1.14 Million | 7.24 Million | 442 Thousand | 3.38 Million |
| Cash at end of period | -1.7 Million | 4.24 Million | 5.95 Million | 5.95 Million | 1.14 Million | 442 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.7 Million | -1.7 Million | 4.8 Million | -1.28 Million | 705 Thousand | -2.94 Million |
| Free Cash Flow | -1.7 Million | -1.7 Million | -755 Thousand | -4.85 Million | -795 Thousand | -1.63 Million |
SHUBHAM
MPL
TTFL
THCH
2034
EVSV